Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Atadja

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphomaLeigh Ellis, Yan Pan, Gordon K Smyth, et al.
Blood|October 16, 2009
Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cellsYongchao Wang, Warren Fiskus, Daniel G Chong, et al.
Molecular Cell|January 7, 2014
Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemiaFang Cao, Elizabeth C Townsend, Hacer Karatas, et al.
Analytical Biochemistry|February 21, 2012
Detecting S-adenosyl-L-methionine-induced conformational change of a histone methyltransferase using a homogeneous time-resolved fluorescence-based binding assayYing Lin, Hong Fan, Mathias Frederiksen, et al.
Analytical Chemistry|August 29, 2014
Absolute quantification of histone PTM marks by MRM-based LC-MS/MSJun Gao, Rijing Liao, Yanyan Yu, et al.
BMC International Health and Human Rights|July 31, 2012
Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continentSolomon Nwaka, Alexander Ochem, Dominique Besson, et al.
Journal of Medicinal Chemistry|March 9, 2010
Conformational refinement of hydroxamate-based histone deacetylase inhibitors and exploration of 3-piperidin-3-ylindole analogues of dacinostat (LAQ824)Young Shin Cho, Lewis Whitehead, Jianke Li, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 23, 2018
Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor DomainGuillermo Senisterra, Hugh Y Zhu, Xiao Luo, et al.
Oncotarget|November 22, 2017
Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cellsJianwu Fang, Haiyan Ying, Ting Mao, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2011
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitorsMichael Shultz, Jianmei Fan, Christine Chen, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphomaLeigh Ellis, Yan Pan, Gordon K Smyth, et al.
Blood|October 16, 2009
Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cellsYongchao Wang, Warren Fiskus, Daniel G Chong, et al.
Molecular Cell|January 7, 2014
Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemiaFang Cao, Elizabeth C Townsend, Hacer Karatas, et al.
Analytical Biochemistry|February 21, 2012
Detecting S-adenosyl-L-methionine-induced conformational change of a histone methyltransferase using a homogeneous time-resolved fluorescence-based binding assayYing Lin, Hong Fan, Mathias Frederiksen, et al.
Analytical Chemistry|August 29, 2014
Absolute quantification of histone PTM marks by MRM-based LC-MS/MSJun Gao, Rijing Liao, Yanyan Yu, et al.
BMC International Health and Human Rights|July 31, 2012
Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continentSolomon Nwaka, Alexander Ochem, Dominique Besson, et al.
Journal of Medicinal Chemistry|March 9, 2010
Conformational refinement of hydroxamate-based histone deacetylase inhibitors and exploration of 3-piperidin-3-ylindole analogues of dacinostat (LAQ824)Young Shin Cho, Lewis Whitehead, Jianke Li, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 23, 2018
Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor DomainGuillermo Senisterra, Hugh Y Zhu, Xiao Luo, et al.
Oncotarget|November 22, 2017
Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cellsJianwu Fang, Haiyan Ying, Ting Mao, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2011
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitorsMichael Shultz, Jianmei Fan, Christine Chen, et al.
Pageof 11